Evidence map›Paper›PMID 42257244›Full record

ArticleAnnals of clinical and translational neurology2026

Human Pegivirus Encephalitis With Brain Detection and Response to Sofosbuvir Ledipasvir.

Antoine Moulignier, Françoise Heran, Francis Lallemand, Pierre Bourdillon

Abstract readCase Reports
In one paragraph

Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Antoine MoulignierDepartment of Neurology, Adolphe de Rothschild Foundation Hospital, Paris, France.ORCID https://orcid.org/0000-0001-7566-0175
Françoise HeranDepartment of Neuroradiology, Adolphe de Rothschild Foundation Hospital, Paris, France.
Francis LallemandDepartment of Infectious and Tropical Diseases, APHP, Saint Antoine University Hospital, Paris, France.
Pierre BourdillonDepartment of Neurosurgery, Adolphe de Rothschild Foundation Hospital, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human pegivirus (HPgV-1) has been associated with severe encephalomyelitis in immunocompromised patients. Its neurological spectrum remains poorly defined. We report a slowly progressive encephalitis in a person living with well-controlled HIV, characterized by white matter abnormalities and inflammatory cerebrospinal fluid (CSF). HPgV RNA was detected in CSF and brain tissue by metagenomic sequencing, with no alternative pathogen identified. Following off-label treatment with sofosbuvir/ledipasvir, the patient showed sustained clinical improvement, normalization of CSF findings, and disappearance of detectable HPgV RNA. This observation expands the clinical context of HPgV-1 detection and supports further investigation of its role in central nervous system disease.

Indexed as

Antiviral AgentsBenzimidazolesEncephalitis, ViralFlaviviridae InfectionsFluorenesPegivirusSofosbuvirBrainHumansMaleAntiviral AgentsBenzimidazolesFluorenesSofosbuvirencephalitisHIV infectionHPgVhuman pegivirus

Identifiers

PMID42257244
PMCPMC13394788

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.